Research led by the Centenary Institute in Sydney has found a brand new target for treating drug resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body’s blood clotting system to weaken our immune systems.
Tuberculosis is far from eradicated around the world and still infects more than 1,400 people per year in Australia. Antibiotic resistant tuberculosis is particularly deadly and expensive to treat,
costing up to $250,000 to treat a single case in Australia. Scientists at the Centenary Institute have been working on new ways to treat tuberculosis by increasing the effectiveness of the immune
Using the zebrafish model of tuberculosis, the researchers used fluorescent microscopy to observe the build-up of clots and activation of platelets around sites of infection . Senior author and head of the Centenary’s Immune-Vascular Interactions laboratory, Dr Stefan Oehlers, says “the zebrafish gives us literal insight into disease processes by watching cells interacting in real time”.
Following their hunch that these platelets were being tricked by the infection into getting in the way of the body’s immune system, the researchers treated infections with anti-platelet drugs, including widely available aspirin, and were able to prevent hijacking and allow the body to control infection better.
Dr Elinor Hortle, lead author of the paper published in The Journal of Infectious Diseases, and Research Officer in Centenary’s Immune-Vascular Interactions laboratory says “This is the first
time that platelets have been found to worsen tuberculosis in an animal model. It opens up the possibility that anti-platelet drugs could be used to help the immune system fight off drug resistant
There are over 1.2 million Australians living with latent tuberculosis, a non-infectious form of TB that puts them at risk of developing the active disease. “Our study provides more crucial evidence
that widely available aspirin could be used to treat patients with severe tuberculosis infection and save lives,” says Dr Hortle.
Video 1 – Green platelets
zooming around the
vasculature of a zebrafish
embryo. Note some platelets
stick to red macrophages
infected by blue bacteria
Video 2 – Zoomed in version
of video 1 with visible blood
Green platelets sticking to
red blood vessels next to
sites of infection by blue
bacteria. Pathogenic platelets
are the green cells that stick
next to the bacteria for a few
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- Tuberculosis remains SA’s single largest contributor to deathon June 17, 2021 at 10:45 pm
Tuberculosis (TB) remained the leading cause of death in South Africa between 2016-2018 according to a report by Statistics South Africa ...
- Study validates accuracy of new molecular test for tuberculosis diagnosison June 17, 2021 at 6:41 pm
Tuberculosis (TB) is the leading cause of death by an infectious agent, worldwide. In 2019, 1.4 million people are estimated to have died and 10 million people fell sick from TB, although only 70% of ...
- Delaware Suit May Be First of Many Over Bone Graft Linked to Tuberculosison June 17, 2021 at 2:09 pm
A case filed in Delaware Superior Court is the first anywhere to claim Aziyo Inc. was negligent in sending out a bone marrow product thought to be contaminated with tuberculosis, but attorneys for the ...
- A better molecular test to detect tuberculosison June 17, 2021 at 9:25 am
This is the main conclusion of a study performed by ISGlobal, an institution supported by "la Caixa" Foundation, in collaboration with the Manhiça Health Research Centre (CISM), published in the ...
- Praedicare Inc. Receives Grant to Evaluate Potential New Drug Regimens for Tuberculosison June 17, 2021 at 8:30 am
Praedicare Inc., a CRO using unique pre-clinical laboratory and proprietary mathematical translation models today announced it has been awarded a two-year, $2.8 million grant by the Bill & Melinda ...
- Tuberculosis Testing Market Research Report by Test Type, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19on June 17, 2021 at 3:41 am
Tuberculosis Testing Market Research Report by Test Type (Culture Based Tests, Drug Susceptibility Testing, and Nucleic Acid Testing), by End User (Hospital and Laboratories), by ...
- SARS-CoV-2 May Have the Ability To Reactivate Dormant Tuberculosison June 17, 2021 at 2:32 am
In a study, scientists found that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis in mice.
- Bone repair product linked to tuberculosis cases in Allen Countyon June 16, 2021 at 1:34 pm
Cases of tuberculosis were discovered in five Allen County patients after they received the bone repair product.
- 4 Inmates May Have Contracted Tuberculosis in Georgia Prisonon June 12, 2021 at 8:55 am
At least four inmates may have contracted tuberculosis at a privately run state prison in south Georgia. ALAMO, Ga. (AP) — At least four inmates may have contracted tuberculosis at a privately run ...
- 4 inmates may have contracted tuberculosis in Georgia prison | Raleigh News & Observeron June 12, 2021 at 7:56 am
ALAMO, Ga. At least four inmates may have contracted tuberculosis at a privately run state prison in south Georgia. The Georgia Department of Public Health tells WMAZ-TV that one ...
via Bing News